Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary : Global Kinase Inhibitors Market


4. Market Overview

4.1. Introduction & Overview

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Porter’s Five Forces Analysis

4.4. Global Kinase Inhibitors Market Analysis and Forecast, 2017–2027


5. Market Outlook

5.1. Pipeline Analysis

5.2. Brand Analysis

5.3. Recent Developments In Kinase Inhibitors Research


6. Global Kinase Inhibitors Market Analysis and Forecasts, by Type

6.1. Introduction & Definition

6.2. Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

6.2.1. Non-receptor Tyrosine Kinase Inhibitors

6.2.1.1. Bruton’s Tyrosine Kinase (BTK) Inhibitors

6.2.1.2. BCR-ABL

6.2.1.3. Janus Kinase (JAK) Inhibitor

6.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)

6.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors

6.2.1.6. Others

6.2.2. Receptor Tyrosine Kinase Inhibitors

6.2.2.1. VEGFR

6.2.2.2. PDGFR

6.2.2.3. EGFR

6.2.2.4. ALK

6.2.2.5. HER2

6.2.2.6. Others

6.2.3. Multikinase inhibitors

6.2.4. Serine/Threonine Kinase Inhibitors

6.2.5. Protein Kinase C Inhibitors

6.2.6. RHO Kinase Inhibitors

6.2.7. Others

6.3. Global Kinase Inhibitors Market Attractiveness, by Type


7. Global Kinase Inhibitors Market Analysis and Forecasts, by Application

7.1. Introduction & Definition

7.2. Global Kinase Inhibitors Market Value (US$) Forecast, by Application, 2017–2027

7.2.1. Oncology

7.2.1.1. Lung Cancer

7.2.1.2. Renal cell cancer

7.2.1.3. Breast Cancer

7.2.1.4. Others

7.2.2. Inflammatory Diseases

7.2.3. Others

7.3. Global Kinase Inhibitors Market Attractiveness, by Application


8. Global Kinase Inhibitors Market Analysis and Forecasts, by Distribution Channel

8.1. Introduction & Definition

8.2. Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

8.2.1. Hospital Pharmacies

8.2.2. Independent Pharmacies

8.2.3. Online Pharmacies

8.3. Global Kinase Inhibitors Market Attractiveness, by Distribution Channel


9. Global Kinase Inhibitors Market Analysis and Forecasts, by Region

9.1. Key Findings

9.2. Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Kinase Inhibitors Market Attractiveness, by Region


10. North America Kinase Inhibitors Market Analysis and Forecast

10.1. Introduction

10.2. North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

10.2.1. Non-receptor Tyrosine Kinase Inhibitors

10.2.1.1. Bruton’s Tyrosine Kinase (BTK) Inhibitors

10.2.1.2. BCR-ABL

10.2.1.3. Janus Kinase (JAK) Inhibitor

10.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)

10.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors

10.2.1.6. Others

10.2.2. Receptor Tyrosine Kinase Inhibitors

10.2.2.1. VEGFR

10.2.2.2. PDGFR

10.2.2.3. EGFR

10.2.2.4. ALK

10.2.2.5. HER2

10.2.2.6. Others

10.2.3. Multikinase inhibitors

10.2.4. Serine/Threonine Kinase Inhibitors

10.2.5. Protein Kinase C Inhibitors

10.2.6. RHO Kinase Inhibitors

10.2.7. Others

10.3. North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

10.3.1. Oncology

10.3.1.1. Lung Cancer

10.3.1.2. Renal cell cancer

10.3.1.3. Breast Cancer

10.3.1.4. Others

10.3.2. Inflammatory Diseases

10.3.3. Others

10.4. North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

10.4.1. Hospital Pharmacies

10.4.2. Independent Pharmacies

10.4.3. Online Pharmacies

10.5. North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Kinase Inhibitors Market Attractiveness Analysis

10.6.1. By Type

10.6.2. By Application

10.6.3. By Distribution Channel

10.6.4. By Country


11. Europe Kinase Inhibitors Market Analysis and Forecast

11.1. Introduction

11.2. Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

11.2.1. Non-receptor Tyrosine Kinase Inhibitors

11.2.1.1. Bruton’s Tyrosine Kinase (BTK) Inhibitors

11.2.1.2. BCR-ABL

11.2.1.3. Janus Kinase (JAK) Inhibitor

11.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)

11.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors

11.2.1.6. Others

11.2.2. Receptor Tyrosine Kinase Inhibitors

11.2.2.1. VEGFR

11.2.2.2. PDGFR

11.2.2.3. EGFR

11.2.2.4. ALK

11.2.2.5. HER2

11.2.2.6. Others

11.2.3. Multikinase inhibitors

11.2.4. Serine/Threonine Kinase Inhibitors

11.2.5. Protein Kinase C Inhibitors

11.2.6. RHO Kinase Inhibitors

11.2.7. Others

11.3. Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

11.3.1. Oncology

11.3.1.1. Lung Cancer

11.3.1.2. Renal cell cancer

11.3.1.3. Breast Cancer

11.3.1.4. Others

11.3.2. Inflammatory Diseases

11.3.3. Others

11.4. Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

11.4.1. Hospital Pharmacies

11.4.2. Independent Pharmacies

11.4.3. Online Pharmacies

11.5. Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Kinase Inhibitors Market Attractiveness Analysis

11.6.1. By Type

11.6.2. By Application

11.6.3. By Distribution Channel

11.6.4. By Country/Sub-region

12. Asia Pacific Kinase Inhibitors Market Analysis and Forecast

12.1. Introduction

12.2. Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

12.2.1. Non-receptor Tyrosine Kinase Inhibitors

12.2.1.1. Bruton’s Tyrosine Kinase (BTK) Inhibitors

12.2.1.2. BCR-ABL

12.2.1.3. Janus Kinase (JAK) Inhibitor

12.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)

12.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors

12.2.1.6. Others

12.2.2. Receptor Tyrosine Kinase Inhibitors

12.2.2.1. VEGFR

12.2.2.2. PDGFR

12.2.2.3. EGFR

12.2.2.4. ALK

12.2.2.5. HER2

12.2.2.6. Others

12.2.3. Multikinase inhibitors

12.2.4. Serine/Threonine Kinase Inhibitors

12.2.5. Protein Kinase C Inhibitors

12.2.6. RHO Kinase Inhibitors

12.2.7. Others

12.3. Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

12.3.1. Oncology

12.3.1.1. Lung Cancer

12.3.1.2. Renal cell cancer

12.3.1.3. Breast Cancer

12.3.1.4. Others

12.3.2. Inflammatory Diseases

12.3.3. Others

12.4. Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

12.4.1. Hospital Pharmacies

12.4.2. Independent Pharmacies

12.4.3. Online Pharmacies

12.5. Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Kinase Inhibitors Market Attractiveness Analysis

12.6.1. By Type

12.6.2. By Application

12.6.3. By Distribution Channel

12.6.4. By Country/Sub-region


13. Latin America Kinase Inhibitors Market Analysis and Forecast

13.1. Introduction

13.2. Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

13.2.1. Non-receptor Tyrosine Kinase Inhibitors

13.2.1.1. Bruton’s Tyrosine Kinase (BTK) Inhibitors

13.2.1.2. BCR-ABL

13.2.1.3. Janus Kinase (JAK) Inhibitor

13.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)

13.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors

13.2.1.6. Others

13.2.2. Receptor Tyrosine Kinase Inhibitors

13.2.2.1. VEGFR

13.2.2.2. PDGFR

13.2.2.3. EGFR

13.2.2.4. ALK

13.2.2.5. HER2

13.2.2.6. Others

13.2.3. Multikinase inhibitors

13.2.4. Serine/Threonine Kinase Inhibitors

13.2.5. Protein Kinase C Inhibitors

13.2.6. RHO Kinase Inhibitors

13.2.7. Others

13.3. Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

13.3.1. Oncology

13.3.1.1. Lung Cancer

13.3.1.2. Renal cell cancer

13.3.1.3. Breast Cancer

13.3.1.4. Others

13.3.2. Inflammatory Diseases

13.3.3. Others

13.4. Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

13.4.1. Hospital Pharmacies

13.4.2. Independent Pharmacies

13.4.3. Online Pharmacies

13.5. Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Kinase Inhibitors Market Attractiveness Analysis

13.6.1. By Type

13.6.2. By Application

13.6.3. By Distribution Channel

13.6.4. By Country/Sub-region


14. Middle East & Africa Kinase Inhibitors Market Analysis and Forecast

14.1. Introduction

14.2. Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

14.2.1. Non-receptor Tyrosine Kinase Inhibitors

14.2.1.1. Bruton’s Tyrosine Kinase (BTK) Inhibitors

14.2.1.2. BCR-ABL

14.2.1.3. Janus Kinase (JAK) Inhibitor

14.2.1.4. Mesenchymal Epithelial Transition Growth Factor (c-MET)

14.2.1.5. Spleen Tyrosine Kinase (SYK) Inhibitors

14.2.1.6. Others

14.2.2. Receptor Tyrosine Kinase Inhibitors

14.2.2.1. VEGFR

14.2.2.2. PDGFR

14.2.2.3. EGFR

14.2.2.4. ALK

14.2.2.5. HER2

14.2.2.6. Others

14.2.3. Multikinase inhibitors

14.2.4. Serine/Threonine Kinase Inhibitors

14.2.5. Protein Kinase C Inhibitors

14.2.6. RHO Kinase Inhibitors

14.2.7. Others

14.3. Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

14.3.1. Oncology

14.3.1.1. Lung Cancer

14.3.1.2. Renal cell cancer

14.3.1.3. Breast Cancer

14.3.1.4. Others

14.3.2. Inflammatory Diseases

14.3.3. Others

14.4. Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

14.4.1. Hospital Pharmacies

14.4.2. Independent Pharmacies

14.4.3. Online Pharmacies

14.5. Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Israel

14.5.4. Rest of Middle East & Africa

14.6. Middle East & Africa Kinase Inhibitors Market Attractiveness Analysis

14.6.1. By Type

14.6.2. By Application

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region


15. Competition Landscape

15.1. Competition Matrix

15.2. Market Share Analysis, by Company (2018)

15.3. Company Profiles

15.3.1. Boehringer Ingelheim International GmbH

15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.1.2. Company Financials

15.3.1.3. Growth Strategies

15.3.1.4. SWOT Analysis

15.3.2. Novartis AG

15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.2.2. Company Financials

15.3.2.3. Growth Strategies

15.3.2.4. SWOT Analysis

15.3.3. AstraZeneca plc

15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.3.2. Company Financials

15.3.3.3. Growth Strategies

15.3.3.4. SWOT Analysis

15.3.4. Pfizer, Inc.

15.3.4.1. Company Overview (HQ, Business Segments)

15.3.4.2. Company Financials

15.3.4.3. Growth Strategies

15.3.4.4. SWOT Analysis

15.3.5. F. Hoffmann-La Roche Ltd

15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.5.2. Company Financials

15.3.5.3. Growth Strategies

15.3.5.4. SWOT Analysis

15.3.6. Bristol-Myers Squibb Company

15.3.6.1. Company Overview (HQ, Business Segments)

15.3.6.2. Company Financials

15.3.6.3. Growth Strategies

15.3.6.4. SWOT Analysis

15.3.7. Johnson & Johnson

15.3.7.1. Company Overview (HQ, Business Segments)

15.3.7.2. Company Financials

15.3.7.3. Growth Strategies

15.3.7.4. SWOT Analysis

15.3.8. Bayer AG

15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.8.2. Company Financials

15.3.8.3. Growth Strategies

15.3.8.4. SWOT Analysis

15.3.9. Eisai Co., Ltd.

15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.9.2. Company Financials

15.3.9.3. Growth Strategies

15.3.9.4. SWOT Analysis



List of Figures



Figure 01: Global Kinase Inhibitors Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, 2017–2027

Figure 03: Clinical Trial Analysis, by Phase

Figure 04: Clinical Trial Analysis, by Status

Figure 05: Global Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027

Figure 06: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017–2027

Figure 07: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017–2027

Figure 08: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Multikinase inhibitors, 2017–2027

Figure 09: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Serine/Threonine Kinase Inhibitors, 2017–2027

Figure 10: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Protein Kinase C Inhibitors, 2017–2027

Figure 11: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by RHO Kinase Inhibitors, 2017–2027

Figure 12: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027

Figure 13: Global Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019–2027

Figure 14: Global Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027

Figure 15: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oncology, 2017–2027

Figure 16: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Inflammatory Diseases, 2017–2027

Figure 17: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027

Figure 18: Global Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019–2027

Figure 19: Global Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 20: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacies, 2017–2027

Figure 21: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017–2027

Figure 22: Global Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017–2027

Figure 23: Global Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 24: Global Kinase Inhibitors Market Value Share Analysis, by Region, 2018 and 2027

Figure 25: Global Kinase Inhibitors Market Attractiveness Analysis, by Region, 2019–2027

Figure 26: North America Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 27: North America Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027

Figure 28: North America Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019–2027

Figure 29: North America Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027

Figure 30: North America Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019–2027

Figure 31: North America Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 32: North America Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 33: North America Kinase Inhibitors Market Value Share Analysis, by Country, 2018 and 2027

Figure 34: North America Kinase Inhibitors Market Attractiveness Analysis, by Country, 2019–2027

Figure 35: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 36: Europe Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027

Figure 37: Europe Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019–2027

Figure 38: Europe Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027

Figure 39: Europe Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019–2027

Figure 40: Europe Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 41: Europe Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 42: Europe Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 43: Europe Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 44: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 45: Asia Pacific Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027

Figure 46: Asia Pacific Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019–2027

Figure 47: Asia Pacific Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027

Figure 48: Asia Pacific Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019–2027

Figure 49: Asia Pacific Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 50: Asia Pacific Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 51: Asia Pacific Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 52: Asia Pacific Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 53: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 54: Latin America Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027

Figure 55: Latin America Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019–2027

Figure 56: Latin America Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027

Figure 57: Latin America Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019–2027

Figure 58: Latin America Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 59: Latin America Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 60: Latin America Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 61: Latin America Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 62: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 63: Middle East & Africa Kinase Inhibitors Market Value Share Analysis, by Type, 2018 and 2027

Figure 64: Middle East & Africa Kinase Inhibitors Market Attractiveness Analysis, by Type, 2019–2027

Figure 65: Middle East & Africa Kinase Inhibitors Market Value Share Analysis, by Application, 2018 and 2027

Figure 66: Middle East & Africa Kinase Inhibitors Market Attractiveness Analysis, by Application, 2019–2027

Figure 67: Middle East & Africa Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 68: Middle East & Africa Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 69: Middle East & Africa Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 70: Middle East & Africa Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 71: Global Kinase Inhibitors Market Share, by Company, 2018


List of Tables


List of Tables

Table 01: Global BCR-ABL Tyrosine Kinase Inhibitors Market Revenue (US$ Mn) Forecast, by Key Brands, 2016-2026

Table 02: Global EGFR Tyrosine Kinase Inhibitors Market Revenue (US$ Mn) Forecast, by Key Brands, 2016-2026

Table 03: Global VEGFR Tyrosine Kinase Inhibitors Market Revenue (US$ Mn) Forecast, by Key Brands, 2016-2026

Table 04: Global Other Tyrosine Kinase Inhibitors Market Revenue (US$ Mn) Forecast, by Key Brands, 2016-2026

Table 05: Patent & Market Exclusivity Overview, by Molecule (1/4)

Table 06: Patent & Market Exclusivity Overview, by Molecule (2/4)

Table 07: Patent & Market Exclusivity Overview, by Molecule (3/4)

Table 08: Patent & Market Exclusivity Overview, by Molecule (4/4)

Table 09: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 10: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 11: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 12: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 13: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017–2027

Table 14: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: Global Kinase Inhibitors Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 16: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 17: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 18: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 19: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 20: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017–2027

Table 21: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 22: North America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 23: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 24: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 25: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 26: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 27: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017–2027

Table 28: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 29: Europe Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 31: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 32: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 33: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 34: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017–2027

Table 35: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 36: Asia Pacific Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 37: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 38: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 39: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 40: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 41: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017–2027

Table 42: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 43: Latin America Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 44: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 45: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Non-receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 46: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Receptor Tyrosine Kinase Inhibitors, 2017–2027

Table 47: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 48: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Oncology, 2017–2027

Table 49: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 50: Middle East & Africa Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027